ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nym Rated a Top Performer by KLAS in First Report Dedicated to Autonomous Medical Coding

By: via Business Wire

Report underscores autonomous coding’s rapid adoption and Nym’s role in delivering efficiency and scalability to healthcare provider organizations

Nym, a leader in autonomous medical coding, has been rated by KLAS Research as a top performer in the first report dedicated to the autonomous coding market: "Autonomous Coding 2025: A Promising Start for an Early Market.” The August 2025 report formally recognizes autonomous coding as a distinct and growing segment within healthcare technology and highlights the vendors driving measurable value for providers.

Key Takeaways

  • Nym’s Overall Performance Score: 89.6 (based on evaluations from 12 unique Nym customers)
  • Customer feedback highlights: High satisfaction with implementation and ongoing support, including onboarding and training processes that ensure a smooth go-live and ease user adoption

Read the full report.

KLAS’s findings show that autonomous medical coding is gaining momentum, with the most significant adoption today in radiology and emergency department settings, areas where providers are realizing substantial efficiency and accuracy gains. Customers across the market are eager to extend autonomous coding to additional specialties, underscoring its potential to address coding-related staffing shortages and operational bottlenecks.

Nym’s performance in the report reflects its ability to deliver the outcomes healthcare organizations are prioritizing as they scale autonomous coding. By fully automating coding with no human intervention, Nym eliminates overtime costs and contract labor needs while ensuring charts are coded in seconds, helping providers accelerate payment cycles and reduce administrative burden. Customers in the report consistently credited Nym’s thoughtful onboarding and training for enabling a smooth go-live, rapid user adoption, and sustained productivity gains; capabilities essential for long-term success.

The report’s customer perspectives bring these outcomes to life. "Nym’s [autonomous medical coding engine] has completely transformed our ability to get through the volume of accounts. And one of our hospitals has a department that is one of the busiest in the country. I cut my need for human coders in half with this solution. And it was not that we eliminated all the positions. We just got rid of the overtime so our people can breathe now. We don’t need to use contractors anymore, and we don’t have open positions anymore. The solution has literally transformed our department. I cannot say enough good things about Nym.” - Director, Autonomous Coding 2025: A Promising Start for an Early Market, August 2025.

“KLAS’s first report focused solely on autonomous coding marks a meaningful step forward for the industry,” said Or Peles, CEO of Nym. “Nym’s recognition as a top performer speaks to the progress we’re making with providers today and the potential to deliver even greater value as adoption expands.”

Nym currently partners with over 25 healthcare organizations nationwide, including leading health systems, hospitals, and provider groups.

About Nym

Nym is the leader in transforming clinical language into actionable information, removing inefficiencies that add billions to the cost of care. By combining industry-leading technology with clinical expertise and a deep understanding of medical language, Nym accurately decodes medical charts in a way that is fast, explainable, and compliant. The Company’s innovative autonomous medical coding solution translates provider notes into accurate diagnostic and billing codes in seconds, with zero human intervention and over 95% accuracy. Nym’s solution delivers audit-ready documentation for every code it generates, ensuring complete visibility into coding decisions. Based in New York City with R&D capabilities in Tel Aviv, Nym is backed by leading investors including PSG, Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, and Tiger Global. Learn more at nym.health.

KLAS is a research and insights firm on a mission to improve healthcare delivery by amplifying the provider’s voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, and medical equipment to deliver timely reports and statistical overviews. Learn more at klasresearch.com.

Nym currently partners with over 25 healthcare organizations nationwide, including leading health systems, hospitals, and provider groups.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.